zip >>> 60064
sector >>> Healthcare
fullTimeEmployees >>> 47000
longBusinessSummary >>> AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the United States, Japan, Germany, Canada, France, Spain, Italy, the Netherlands, the United Kingdom, Brazil, and internationally. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal BehÃ§et's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheumatoid arthritis in adult patients; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), mantle cell lymphoma, waldenstrÃ¶m's macroglobulinemia, marginal zone lymphoma, and chronic graft versus host disease; VENCLEXTA, a BCL-2 inhibitor used to treat adults with CLL or SLL; VIEKIRA PAK, an interferon-free therapy to treat adults with genotype 1 chronic hepatitis C virus (HCV); TECHNIVIE to treat adults with genotype 4 HCV infection; and MAVYRET to treat patients with chronic HCV genotype 1-6 infection. It also provides SYNAGIS that protects at-risk infants from severe respiratory disease; KALETRA, a prescription anti-HIV-1 medicine; CREON, a pancreatic enzyme therapy for exocrine pancreatic insufficiency; Synthroid used in the treatment of hypothyroidism; AndroGel for males diagnosed with symptomatic low testosterone; and Lupron, a product for the palliative treatment of advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids. In addition, the company offers ORILISSA, a nonpeptide small molecule gonadotropin-releasing hormone antagonist; Duopa and Duodopa, a levodopa-carbidopa intestinal gel to treat Parkinson's disease; and Sevoflurane, an anesthesia product. It has collaborations with Calico Life Sciences LLC; Alector, Inc.; Janssen Biotech, Inc.; Jacobio Pharmaceuticals; I-Mab; and Genmab A/S. The company was incorporated in 2012 and is based in North Chicago, Illinois.
city >>> North Chicago
phone >>> 847 932 7900
state >>> IL
country >>> United States
companyOfficers >>> []
website >>> http://www.abbvie.com
maxAge >>> 1
address1 >>> 1 North Waukegan Road
industry >>> Drug Manufacturers—General
previousClose >>> 85.91
regularMarketOpen >>> 86
twoHundredDayAverage >>> 89.31906
trailingAnnualDividendYield >>> 0.053660806
payoutRatio >>> 0.9847
volume24Hr >>> None
regularMarketDayHigh >>> 86.86
navPrice >>> None
averageDailyVolume10Day >>> 7783085
totalAssets >>> None
regularMarketPreviousClose >>> 85.91
fiftyDayAverage >>> 92.19559
trailingAnnualDividendRate >>> 4.61
open >>> 86
toCurrency >>> None
averageVolume10days >>> 7783085
expireDate >>> None
yield >>> None
algorithm >>> None
dividendRate >>> 4.72
exDividendDate >>> 1602633600
beta >>> 0.716833
circulatingSupply >>> None
startDate >>> None
regularMarketDayLow >>> 85.46
priceHint >>> 2
currency >>> USD
trailingPE >>> 19.064781
regularMarketVolume >>> 9432704
lastMarket >>> None
maxSupply >>> None
openInterest >>> None
marketCap >>> 152181293056
volumeAllCurrencies >>> None
strikePrice >>> None
averageVolume >>> 6964533
priceToSalesTrailing12Months >>> 4.2007704
dayLow >>> 85.46
ask >>> 86.3
ytdReturn >>> None
askSize >>> 800
volume >>> 9432704
fiftyTwoWeekHigh >>> 101.28
forwardPE >>> 7.120562
fromCurrency >>> None
fiveYearAvgDividendYield >>> 4.02
fiftyTwoWeekLow >>> 62.55
bid >>> 86.15
tradeable >>> False
dividendYield >>> 0.054899998
bidSize >>> 800
dayHigh >>> 86.86
exchange >>> NYQ
shortName >>> AbbVie Inc.
longName >>> AbbVie Inc.
exchangeTimezoneName >>> America/New_York
exchangeTimezoneShortName >>> EDT
isEsgPopulated >>> False
gmtOffSetMilliseconds >>> -14400000
quoteType >>> EQUITY
symbol >>> ABBV
messageBoardId >>> finmb_141885706
market >>> us_market
annualHoldingsTurnover >>> None
enterpriseToRevenue >>> 6.449
beta3Year >>> None
profitMargins >>> 0.19204001
enterpriseToEbitda >>> 13.966
52WeekChange >>> 0.13880086
morningStarRiskRating >>> None
forwardEps >>> 12.11
revenueQuarterlyGrowth >>> None
sharesOutstanding >>> 1764829952
fundInceptionDate >>> None
annualReportExpenseRatio >>> None
bookValue >>> 8.337
sharesShort >>> 13283560
sharesPercentSharesOut >>> 0.0075
fundFamily >>> None
lastFiscalYearEnd >>> 1577750400
heldPercentInstitutions >>> 0.76761
netIncomeToCommon >>> 6905999872
trailingEps >>> 4.523
lastDividendValue >>> None
SandP52WeekChange >>> 0.108078
priceToBook >>> 10.34305
heldPercentInsiders >>> 0.0011100001
nextFiscalYearEnd >>> 1640908800
mostRecentQuarter >>> 1593475200
shortRatio >>> 1.82
sharesShortPreviousMonthDate >>> 1597363200
floatShares >>> 1762362479
enterpriseValue >>> 233630564352
threeYearAverageReturn >>> None
lastSplitDate >>> None
lastSplitFactor >>> None
legalType >>> None
morningStarOverallRating >>> None
earningsQuarterlyGrowth >>> None
dateShortInterest >>> 1600128000
pegRatio >>> 0.99
lastCapGain >>> None
shortPercentOfFloat >>> 0.0075
sharesShortPriorMonth >>> 12410255
category >>> None
fiveYearAverageReturn >>> None
regularMarketPrice >>> 86
logo_url >>> https://logo.clearbit.com/abbvie.com
